Protocol No.: Amorcyte Study-002; A Prospective Randomized Double Blinded Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients with Acute Myocardial Infarction

Project: Other project

StatusFinished
Effective start/end date2/24/1212/31/16

Funding

  • Amorcyte Incorporated: $158,331.50